Delivery Order SPE2DB25D3008-SPE2DB25FRCRC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,136.36 for 1,440 units/mL of HAVRIX vaccine syringes on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single transaction under the company's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of HAVRIX 1,440 unit/mL syringes, a hepatitis A vaccine product. This non-set-aside, competitively awarded contract is structured as a delivery order with firm fixed pricing and a ceiling value of $3,059.79. The contract is anticipated to reach ultimate completion on July 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $8,753.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,981,944 units of the HAVRIX 720 Unit/0.5 ML syringe 0.5ML pharmaceutical product. The delivery order has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,439.68 to supply Havrix 1,440 unit/mL syringes. This contract has a completion date of March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and the place of performance is Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply HAVRIX 720 unit/0.5 mL syringes. The $1,373.10 delivery order, which has a completion date of January 16, 2024, is part of the agency's efforts to provide pharmaceuticals and medical supplies to military treatment programs and facilities. AmerisourceBergen Drug Corp, as a prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a total ceiling value of $3,215.14 and is a firm fixed price delivery order with a period of performance through May 9, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with expertise...
- This is a $2,024.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product, with a period of performance through June 16, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/mL syringes. The contract has a ceiling value of $2,286.60 and a period of performance through September 9, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to the U.S. government,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The $1,348.28 award has a completion date of December 22, 2023. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous prior contract awards from DLA to supply pharmaceuticals, medical supplies, and distribution services in...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $1,750.79 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML. The delivery order has a completion date of February 2, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCRCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes, with a ceiling value of $1,012.20 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that supports military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills vaccine and pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Havrix vaccines aligns with the company's extensive portfolio of brand-name medications, vaccines, medical supplies, and specialized healthcare commodities across multiple therapeutic domains. The award demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through competitive procurement processes and its role as a primary supplier within the DLA's global pharmaceutical support network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/21/25 |